Navigation Links
Bayer Issues Additional Guidance to Physicians on Trasylol(R)
Date:10/25/2007

LEVERKUSEN, Germany and WEST HAVEN, Conn., Oct. 25 /PRNewswire/ -- Today Bayer announced new guidance to physicians and health care providers regarding the use of Trasylol(R) (aprotinin injection) in patients at an increased risk of blood loss and blood transfusion undergoing coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB).

The company did so after being notified that the BART Executive Committee had halted the Canadian-based trial -- a randomized, controlled trial being conducted in high-risk cardiac surgery patients. This followed a letter from the BART Data Safety Monitoring Board informing the Committee that a planned periodic data analysis indicated reduced bleeding but also an increase in all-cause mortality (that almost reached conventional statistical significance for 30-day mortality) for patients in the aprotinin treatment arm compared to patients who received either aminocaproic acid or tranexamic acid. Data have not, as yet, been shared with Bayer.

Bayer immediately informed the U.S. Food and Drug Administration (FDA), Health Canada and other health authorities around the world.

Bayer has also been informed that data will now be collected from all centers throughout Canada and data analysis will be undertaken by those conducting the BART study -- a process that is expected to take between four and eight weeks. Consequently no further evaluation either by Bayer or by regulatory authorities can take place until additional information becomes available from the BART investigators.

Guidance from Bayer includes a recommendation that physicians use Trasylol only in accordance with approved product labeling. Trasylol is indicated for prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion.

Additionally
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
3. FDA Issues Safety Alert on Avandia
4. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
5. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
8. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
9. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
10. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
11. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)...  Royal Philips (NYSE: PHG AEX: ... ASTRO,s 56th Annual Meeting in San ... confidence, consistency and accuracy in cancer treatment. Producing quality ... radiation oncology solutions underscore Philips, dedication to leading healthcare ... medicine. "Philips is leveraging our expertise in ...
(Date:9/12/2014)... , Sept. 12, 2014  WellStar Paulding Hospital is ... and became the second in the U.S. to offer ... part of WellStar Health System, Paulding Hospital is on ... latest treatments and solutions. Inspire Therapy offers ... patients who are unable to use traditional treatments, like ...
(Date:9/12/2014)... , September 12, 2014 According ... Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac ... Monitoring), Over the Counter & Prescription Based - Global ... global POC Diagnostics Market over the forecast period of ... at a CAGR of 9.3% from 2013 to 2018, ...
Breaking Medicine Technology:Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3WellStar Pioneers New Sleep Apnea Treatment 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
(Date:9/15/2014)... 2014 Marlton, New Jersey, Sept 9, ... M. Goldstein, of the law firm of Ricci Tyrrell ... the issuance of U.S. Patent No. 8,774,911 from the ... innovative design for a pedicle locator instrument is invented ... a board certified neurosurgeon specializing in minimally-invasive spine surgery. ...
(Date:9/15/2014)... Fancyflyingfox.com, the distinguished wedding dress manufacturer and retailer, ... wedding dresses . All clients can enjoy a greatly ... to 70 percent off. According to the company’s sales ... loyal customers by launching the current sale. , ... different styles of special occasion gowns are provided. All ...
(Date:9/14/2014)... This event allowed the participants to rehearse cooking for ... Social Gastronomy which will be held on 9 October ... bring together a total of 90 participants comprising 30 ... 30 disadvantaged families, forming 30 teams to prepare a ... raise the public’s awareness of reducing food waste, as ...
(Date:9/14/2014)... Proper oral care requires about two minutes ... a way to teach children to brush their teeth ... encourages an effective brushing habit by ensuring that he ... overbrushing, eliminating guesswork and promoting independence and proper oral ... for all children, and producible in design variations. , ...
(Date:9/14/2014)... Transvaginal mesh ( http://www.injurybeacon.com/transvaginal-mesh/ ) lawsuits ... two separate litigations are moving forward in Atlantic County ... to Case Lists updated on September 5th, thousands of ... C.R. Bard Inc., and Johnson & Johnson’s Ethicon unit. ... a total of 1,557 claims have now been filed, ...
Breaking Medicine News(10 mins):Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 2Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 3Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 4Health News:Patent Attorney Stuart M. Goldstein Helps Client Receive a Patent on a Surgical Device designed to Increase Accuracy and Safety in Vertebrae Repair and Attachment 5Health News:Great Discounts On Beach Wedding Dresses Announced By Fancyflyingfox.com Now 2Health News:PolyU Invites Professional Chefs and Grassroot Families to Prepare a Feast Using Unwanted Fresh Food Collected from Local Wet Markets 2Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 2Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 3Health News:New Jersey Litigations Continue to Add Ethicon, C.R. Bard Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports 4
... job strain, long hours to low birth weight , THURSDAY, ... increases the risk of low infant birth weight, a new ... women who filled out a questionnaire on employment and working ... 32 hours or more and high job strain during the ...
... out you,re not alone." , , ARLINGTON, Va., June ... released "Puzzle Pieces," a new public service announcement (PSA) initiative ... to help themselves, their families and their friends who live ... five American families is affected by mental illnesses such as ...
... St. Charles Surgical Hospital (SCSH) ... develop a dedicated and comprehensive lymphedema treatment program complete with trained ... Scott Sullivan and Frank DellaCroce , principal surgeons ... Breast Surgery , have created the first program of its ...
... Hospital for Children ... some things in life are still free thanks to Cox Communications. ... Van Dyck Park in Fairfax, the company hosts its annual ... offering family-friendly entertainment under the stars. This is the seventh ...
... American Indians, Hispanics were most vulnerable, report shows , ... of people who take their own lives are intoxicated ... , From 2001 to 2005, there were an estimated ... those deaths were associated with suicide, according to the ...
... ... ranked among America,s best pediatric institutions by U.S. News & World Report. Children,s ... in eight pediatric subspecialty areas. Ranked in the top 30 of nearly 100 ... their families for more than 135 years. , ...
Cached Medicine News:Health News:NAMI Launches New PSA Campaign 2Health News:St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program 2Health News:St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program 3Health News:Cox Movies Under the Moon(R) Offers Big-Screen Hits Under the Stars 2Health News:Cox Movies Under the Moon(R) Offers Big-Screen Hits Under the Stars 3Health News:Almost Quarter of Suicides Involve Intoxication 2Health News:U.S. News & World Report Ranks Children's National Medical Center among Best Children's Hospitals 2Health News:U.S. News & World Report Ranks Children's National Medical Center among Best Children's Hospitals 3
... Detect™ IgM Capture ELISA is for the ... WNV recombinant antigens (WNRA) in serum as ... of West Nile virus infection in patients ... results must be confirmed by Plaque Reduction ...
Adult; dilates 6.0 to 34.0 French; individually packaged, sterile....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: